CD4 and Hyperkeratosis: In those patients clinically responsive to IA therapy, comparative assessment of histological specimens suggested a decrease of hyperkeratosis, acanthosis, spongiosis, and density of (CD3+, CD4+, and CD1a+) dermal inflammatory infiltrate and total skin‐bound IgE from baseline to week 13 (Figure 6; data not quantified).